Literature DB >> 11349012

Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice.

B Echtenacher1, K Weigl, N Lehn, D N Männel.   

Abstract

The occurrence of peritoneal adhesions in surgical patients is positively correlated with tumor necrosis factor (TNF) levels. In a model of septic peritonitis-cecal ligation and puncture-TNF neutralization prevented formation of peritoneal adhesions and increased mortality, most likely because localization of the septic focus was prevented. To discriminate between the coagulation-independent protective TNF effect and a potential protective procoagulant TNF effect, formation of peritoneal adhesions after CLP was inhibited with heparin, hirudin, or urokinase. Each treatment increased mortality and increased the number of bacteria in the peritoneal lavage fluid, kidney, and liver to various degrees. Under these experimental conditions, antibiotics prevented death. In coagulation-compromised mice, lethality was further enhanced by additional TNF neutralization. These findings demonstrate that peritoneal adhesions early in septic peritonitis are an important mechanism of innate immunity that prevents increased spread of bacteria and reduces mortality.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349012      PMCID: PMC98332          DOI: 10.1128/IAI.69.6.3550-3555.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Modulators of coagulation. A critical appraisal of their role in sepsis.

Authors:  R C Bone
Journal:  Arch Intern Med       Date:  1992-07

2.  Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells.

Authors:  V W van Hinsbergh; T Kooistra; M A Scheffer; J Hajo van Bockel; G N van Muijen
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

Review 3.  Sepsis and septic shock--a review of laboratory models and a proposal.

Authors:  K A Wichterman; A E Baue; I H Chaudry
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

4.  Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis.

Authors:  B Echtenacher; W Falk; D N Männel; P H Krammer
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

5.  Immunologic mast cell-mediated responses and histamine release are attenuated by heparin.

Authors:  J Lucio; J D'Brot; C B Guo; W M Abraham; L M Lichtenstein; A Kagey-Sobotka; T Ahmed
Journal:  J Appl Physiol (1985)       Date:  1992-09

6.  On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.

Authors:  M Lantz; H Thysell; E Nilsson; I Olsson
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

7.  Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis.

Authors:  G J Bagby; K J Plessala; L A Wilson; J J Thompson; S Nelson
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

8.  Tumor necrosis factor (TNF) stimulates plasminogen activator inhibitor (PAI) production by endothelial cells and decreases blood fibrinolytic activity in the rat.

Authors:  A M Dosne; F Dubor; F Lutcher; M Parant; L Chedid
Journal:  Thromb Res Suppl       Date:  1988

9.  Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.

Authors:  M K Eskandari; G Bolgos; C Miller; D T Nguyen; L E DeForge; D G Remick
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

10.  Fibrinolytic response to tumor necrosis factor in healthy subjects.

Authors:  T van der Poll; M Levi; H R Büller; S J van Deventer; J P de Boer; C E Hack; J W ten Cate
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  35 in total

Review 1.  The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death.

Authors:  Ping Qiu; Xizhong Cui; Amisha Barochia; Yan Li; Charles Natanson; Peter Q Eichacker
Journal:  Expert Opin Investig Drugs       Date:  2011-10-01       Impact factor: 6.206

2.  Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice.

Authors:  Zhongshuang Hu; Taisuke Murakami; Kaori Suzuki; Hiroshi Tamura; Johannes Reich; Kyoko Kuwahara-Arai; Toshiaki Iba; Isao Nagaoka
Journal:  Int Immunol       Date:  2016-01-07       Impact factor: 4.823

3.  Seprafilm does not aggravate intraperitoneal septic conditions or evoke systemic inflammatory response.

Authors:  Keiichi Uchida; Hisashi Urata; Yasuhiko Mohri; Mikihiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models.

Authors:  Javier Corral; José Yélamos; David Hernández-Espinosa; Yolanda Monreal; Ruben Mota; Isabel Arcas; Antonia Miñano; Pascual Parrilla; Vicente Vicente
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

5.  Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock.

Authors:  Sébastien Gibot; Cecilia Buonsanti; Frédéric Massin; Michele Romano; Marie-Nathalie Kolopp-Sarda; Fabio Benigni; Gilbert C Faure; Marie-Christine Béné; Paola Panina-Bordignon; Nadia Passini; Bruno Lévy
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 6.  Cytokine orchestration in post-operative peritoneal adhesion formation.

Authors:  Ronan A Cahill; H Paul Redmond
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

Review 7.  [Pathophysiological basis of surgery-linked sepsis].

Authors:  B Vollmar
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

8.  Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot.

Authors:  Krishana C Gulla; Kshitij Gupta; Anders Krarup; Peter Gal; Wilhelm J Schwaeble; Robert B Sim; C David O'Connor; Krishnan Hajela
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

9.  Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis.

Authors:  Michaela Windbichler; Bernd Echtenacher; Thomas Hehlgans; Jens C Jensenius; Wilhelm Schwaeble; Daniela N Männel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis.

Authors:  Deyan Luo; Jr-Shiuan Lin; Michelle A Parent; Isis Mullarky-Kanevsky; Frank M Szaba; Lawrence W Kummer; Debra K Duso; Michael Tighe; Jim Hill; Andras Gruber; Nigel Mackman; David Gailani; Stephen T Smiley
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.